Objective: To evaluate the frequency of adverse events associated with statins use in routine clinical practice in Pakistani population. Methodology: This cross sectional study was conducted at PNS SHIFA a tertiary care hospital in Karachi, Pakistan from January 2015 to December 2015. Male and female patients aged between 20-80 years who were taking statin for more than 3 months and were willing to participate in the study were included. Demographic data like age, gender, medical morbidities e.g. diabetes mellitus , hypertension, ischemic heart disease, cerebrovasculr accident , type and dose of statin and outcome variables like hepatitis, myalgia, myositis and rhabdomyolysis were recorded in a performa. Sample size was calculated using open Epi software. Data was entered and analyzed using SPSS version 21.0. P < 0.05 was taken as significant. Results: A total of 1350 patients aged between 20-80 years of age(Mean age 55.7±10.2 years) were included in the study. There were 53.1 % male patients. Majority of patients (56.9%) were between 41-60 years of age group. About 58.2 % patients had diabetes mellitus ,41.9 % had hypertension,26 % patients had dyslipidimia, 88 % patients were with ischemic heart disease and 9.41 % patients had CVA. Rosuvastatin were prescribed to 56.3% patients, atorvastatin to 33% and simvastatin to 10.7% patients. Regarding the adverse effects, myalgias were most frequently reported in 6.7 % patients; myositis was noted in 0.8 % patients, while rhabdomyolysis was not reported in any patient. Statin induced hepatitis was noted in 2.9%. Conclusion: There is overall a low frequency of adverse events associated with the use of commonly prescribed statins in routine clinical practice. Further large scale studies are needed to validate our findings.